On May 27, 2014, JinkoSolar Holding Co., Ltd. (NYSE:JKS) reported its Q1 2014 unaudited financial results. Total revenues increased 73.1% YoY to RMB 2.0 billion. Net income was registered as RMB 9.5 million, or RMB 0.30 loss per diluted share, compared with net loss of RMB 128.7, or RMB 1.45 loss per diluted share, in Q1 2013. Meanwhile, electricity revenues increased 62.3% QoQ to RMB 48.4 million. Q1 2014 year-on-year increase in total revenues is attributable to shipment increase, improved average selling prices (ASPs) of solar modules and increase in electricity revenues from solar projects. JinkoSolar Holding Co., Ltd. (NYSE:JKS) net profit margin is 4.10% and weekly performance is -4.65%. On last trading day company shares ended up $24.99. Analysts mean target price for the company is $43.82. JinkoSolar Holding Co., Ltd. (NYSE:JKS) distance from 50-day simple moving average (SMA50) is -8.72%.
Investors certainly have to be happy with Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) and its short term performance. After all, the stock has jumped by 14.4% in the past 4 weeks, and it is also above its 20 Day Simple Moving Average as well, according to Zack. Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) shares fell -7.38% in last trading session and ended the day on $3.64. Gross Margin is 27.50 % and its return on assets is -12.60%. Ballard Power Systems Inc. (USA) (NASDAQ:BLDP) quarterly performance is -32.09%.
On June 3, Shares of Endeavour International Corporation (NYSE:END) were the target of unusually large options trading activity on Tuesday. Stock investors acquired 2,381 put options on the stock, Analyst Ratings.Net reports. This represents an increase of approximately 129% compared to the average daily volume of 1,040 put options. Endeavour International Corporation (NYSE:END) shares moved down -5.17% in last trading session and was closed at $1.65, while trading in range of $1.51 – $1.75. Endeavour International Corporation (NYSE:END) year to date (YTD) performance is -1.43%.
Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) tumbled -6.20%, the company recently announced that Chief Executive Officer Mark Baker will present on Thursday, June 5th, at 10:00 AM EDT at the Jefferies Global Healthcare Conference in New York City. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) ended the last trading day at $3.43. Company weekly volatility is calculated as 8.08% and price to cash ratio as 2.54. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) showed a negative weekly performance of -14.89%.
On June 3, Spherix Inc (NASDAQ:SPEX) an intellectual property development company committed to the fostering and monetization of intellectual property, announced that it has completed a $20 million equity financing consisting of 10 million shares of Series J Convertible Preferred Stock (convertible into common stock) at $2 per share to raise gross proceeds of $20 million, before payment of placement agent fees and other expenses of the offering payable by us. No warrants were issued as part of the transaction. Spherix Inc (NASDAQ:SPEX) weekly performance is -47.40%. On last trading day company shares ended up $1.82. Analysts mean target price for the company is $1.00. Spherix Inc (NASDAQ:SPEX) distance from 50-day simple moving average (SMA50) is -14.97%.
Leave a Reply